The Adrenal Gland: Central Relay in Health and Disease

Diseases of the adrenal gland are as important for the general practitioner as for the endocrine specialist. The high prevalence of some adrenal endocrinopathies, such as adrenal incidentalomas (1–2% of the population) and primary aldosteronism (6% of hypertensives), which affect millions of patients, makes adrenal diseases a relevant health issue. The high morbidity and mortality of some of the rarer adrenal diseases, i. e., Addison’s disease and Cushing’s syndrome (Table 1), make early detection and appropriate treatment such a challenge for the health care system.

[1]  N. Reisch Review of Health Problems in Adult Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency , 2019, Experimental and Clinical Endocrinology & Diabetes.

[2]  B. Boehm,et al.  An Update on Addison’s Disease , 2018, Experimental and Clinical Endocrinology & Diabetes.

[3]  M. Fassnacht,et al.  Advanced Adrenocortical Carcinoma – What to do when First-Line Therapy Fails? , 2018, Experimental and Clinical Endocrinology & Diabetes.

[4]  E. Baudin,et al.  Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry. , 2018, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[5]  G. Di Dalmazi Adrenal Incidentaloma : Picking out the High-Risk Patients , 2019 .

[6]  A. Grossman,et al.  Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options , 2018, Experimental and Clinical Endocrinology & Diabetes.

[7]  M. Reincke,et al.  Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification , 2018, Experimental and Clinical Endocrinology & Diabetes.

[8]  M. Bidlingmaier,et al.  Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism , 2018, Experimental and Clinical Endocrinology & Diabetes.

[9]  M. Reincke,et al.  Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure , 2018, Experimental and Clinical Endocrinology & Diabetes.

[10]  C. Dimopoulou,et al.  “The Adrenal Gland: Central Relay in Health and Disease - Current Challenges and Perspectives 2018” – Cushing’s Disease , 2018, Experimental and Clinical Endocrinology & Diabetes.

[11]  F. Beuschlein,et al.  Perioperative Management of Endocrine Active Adrenal Tumors , 2018, Experimental and Clinical Endocrinology & Diabetes.

[12]  F. Beuschlein,et al.  Metabolic Alterations in Patients with Pheochromocytoma , 2018, Experimental and Clinical Endocrinology & Diabetes.

[13]  M. Theodoropoulou,et al.  Genetics of Cushing's disease , 2018, Clinical endocrinology.

[14]  K. Pacak,et al.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification , 2017, Endocrine reviews.

[15]  W. Young,et al.  Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.

[16]  M. Reincke,et al.  Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism , 2017, Hypertension.

[17]  A. Tabarin,et al.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. , 2016, European journal of endocrinology.

[18]  P. Chanson,et al.  Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. , 2015, European journal of endocrinology.

[19]  J. Thigpen Combination Chemotherapy in Advanced Adrenocortical Carcinoma , 2012 .

[20]  F. Veglio,et al.  Prevalence and Characteristics of Familial Hyperaldosteronism: The PATOGEN Study (Primary Aldosteronism in TOrino-GENetic forms) , 2011, Hypertension.

[21]  J. Bertherat,et al.  Cushing's disease. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[22]  M. Srivastava Carney complex. , 2004, Dermatology online journal.

[23]  N. Shimizu [Cushing's disease]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.